Werewolf Therapeutics, Inc. (HOWL) vs Lite Strategy, Inc. (LITS)
A side-by-side comparison of Werewolf Therapeutics, Inc. and Lite Strategy, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HOWL
Werewolf Therapeutics, Inc.
$0.92HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
LITS
Lite Strategy, Inc.
$1.41HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — HOWL vs LITS
growth of $100 · dividends reinvested · last 1yHOWL -32.1% (-32.1%/yr)LITS -69.1% (-69.1%/yr)HOWL compounded faster over this window
HOWL LITS
HOWL vs LITS: by the numbers
- •LITS is the larger company ($48M vs $45M market cap).
- •Both run net losses; LITS's is the smaller (0.00% vs -164.82% net margin).
Metrics side by side
Valuation
| Metric | HOWL | LITS |
|---|---|---|
| P/S ratio | 2.13 | N/A |
| P/B ratio | 2.74 | 1.15 |
Profitability
| Metric | HOWL | LITS |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | -164.82% | 0.00% |
| ROE | -212.45% | -170.94% |
| ROIC | -156.97% | -30.75% |
Growth (annualized)
| Metric | HOWL | LITS |
|---|---|---|
| Total return CAGR (5Y) | -44.27% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.